VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published from Dec 16, 2025 to Jan 4, 2026; they
will resume distribution on Monday, Jan 5, 2026.
|
 |
| December
15, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- AdvaMed: Mick Farrell, Chairman and
CEO of Resmed, Named Chair of Board of
Directors More
More
- Emergent BioSolutions: Receives U.S.
FDA Approval for Drug Product Manufacturing
of raxibacumab at its Winnipeg, Canada Site
More
- NIH: Expanded Umbilical Cord Blood
Transplant Achieves 94% Survival in Severe
Aplastic Anemia Patients More
|
|
|
|
- BrightWave Secures $1M TEDCO Award to Expand
Maryland’s First Fully Integrated Algae
Biomanufacturing Facility More
- Get Discounted Access to Exclusive
VC Funding Data from BYTE51
More
- JPM Week Conference Readiness
Packages (Big4Bio Subscriber Discount) More
|
|
 |
| Struggling
to get attention for your
products and services?
Break through with high-impact
marketing content and campaigns |
|
Learn More
→ |
|
|
- Baltimore Startup Closer to
Opioid-free Pain Treatment With
First-of-Its-Kind Cell Therapy That Absorbs
Pain Signals More
- Biotech Hangout: Episode 166 Podcast
- COVID Vaccine Deaths Review Sent to Top of
FDA, but With Far Less Certain Conclusions,
Sources Say More*
- GAO Probe Finds Understaffed FDA Putting
Some Medical Device Recall Work on the ‘Back
Burner’ More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: Integrating AI into Drug Discovery
Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Capital Region Life
Science Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
showcased by Big4Bio. |
|
|
|
|
|
 |
| M&A
in Life Sciences: The Turning Tide
– Why Now is a Strategic
Inflection for Biopharma and
Biotech |
|
Learn More
→ |
|
|
- Centessa CEO to Step Down; John Maraganore,
Clive Meanwell Find CMO for Their New Cardio
Bet More*
- ICYMI: CEO's Perspective: Big Moves Come
with Big Responsibilities More
- ICYMI: CEO's Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: The Power of Peer Learning: Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Capital
Region, all rights reserved
2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
